Optiflow™ Junior in Practice

Discover how clinicians around the world are using Optiflow™ Junior to improve patient care and outcomes.

The impact of a new therapy at the Rosie

Transforming Respiratory Therapy

Nasal High Flow therapy is being widely adopted in neonatal and pediatric practice. Optiflow™ Junior is designed to enhance the inherent therapy benefits of Nasal High Flow therapy.

Watch this video about a leading tertiary NICU in Cambridge, United Kingdom and their journey to successfully implement Nasal High Flow therapy.

Find out more about how this therapy is transforming the way non invasive respiratory support is being delivered to neonatal and pediatric patients.

Evidence of the Momentum

The use of Nasal High Flow therapy is increasing across the globe. Three surveys of practice found that approximately 70% of respondents across the United Kingdom, United States of America, Australia and New Zealand reported using Nasal High Flow1,2,3.

With growing clinical evidence supporting the therapy, it is helping more premature babies and infants every day.

Optiflow Junior is now available in over 90 countries worldwide.

Optiflow Junior helps neonates, infants and children

Explore how Optiflow Junior has contributed in a shift in clinical practice for both neonates and pediatrics.

Optiflow Junior helps pediatrics

Optiflow Junior helps pediatrics

Newborns breathing easier

Newborns breathing easier

Premature babies could benefit from smaller oxygen devices

Premature babies could benefit from smaller oxygen devices

Optiflow Junior wins Best Design Awards

Explore how Optiflow Junior has been winning internationally recognized design awards.

Optiflow Junior wins Best Design Awards

Optiflow Junior wins Best Design Awards